Hallie Kuhn
Förmögenhet: 2 M $ per 2026-07-31
Förmögenhet: 2 M $ per 2026-07-31
Hallie Kuhn currently works at Molecular Assemblies, Inc., as Director, Eclipse Bioinnovations, Inc., as Director from 2022, Alexandria Real Estate Equities, Inc., as Executive Vice President-Capital Markets from 2026, and Alexandria Venture Investments LLC, as Vice President of Science & Technology.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-17 | 48 301 ( 0,03 % ) | 2 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | Företagsledare/Principal | 2026-01-01 |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Develops enzymatic DNA synthesis technology used for making DNA-based products | Direktör/Styrelseledamot | - |
Eclipse Bioinnovations, Inc.
Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Develops technologies platform for RNA medicines | Direktör/Styrelseledamot | 2022-03-15 |
Alexandria Venture Investments LLC
Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture invests in companies located in the United States. The firm targets companies operating in disruptive life science, innovative medicine and technology. It provides financing for seed, early and growth stage capital requirements. | Privat kapitalinvesterare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities, Inc. Real Estate Investment TrustsFinance Operates as a real estate investment trust which leases life science, agri-tech, and advanced technology mega campuses | Finance |
Alexandria Venture Investments LLC
Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture invests in companies located in the United States. The firm targets companies operating in disruptive life science, innovative medicine and technology. It provides financing for seed, early and growth stage capital requirements. | Finance |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Develops enzymatic DNA synthesis technology used for making DNA-based products | Health Technology |
Eclipse Bioinnovations, Inc.
Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Develops technologies platform for RNA medicines | Technology Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån